본문 바로가기

정책동향

홈 > BT정보 > 정책동향

scrap print facebook twitter me2day
글 읽기

The Canadian Blueprint : Beyond Moose & Mountains

분류 정책동향 > 종합
출처 BIOTECanada 조회 4195
자료발간일 2009-05-01 등록일 2009-07-07
첨부파일

캐나다청사진_beyondmm_english_final.pdf(1073.177 KB)

내용바로가기
평점 평점이 없습니다.
THE CANADIAN BLUEPRINT
HOW WE CAN BUILD THE WORLD’S LEADING BIO-BASED ECONOMY

BEYOND MOOSE AND MOUNTAINS
 
 
CONTENTS
 
About the “Canadian Blueprint” .......3
The Bio-based Economy: Already Shaping Canada’s Society....... 4
Biotechnology: Improving Our Quality of Life .......5
Biotechnology: Powering Canada’s Economy Today, and Into the Future....... 6
The Global Biotechnology Race: Our Prosperity is At Stake....... 8
Building the World’s Leading Bio-based Economy: Canada Can Do It....... 10
The Canadian Blueprint: The Time for Action is Now....... 11
  Blueprint Priority: Capital....... 12
  Blueprint Priority: People .......13
  Blueprint Priority: Operational Environment....... 14
The Canadian Blueprint: How We Will Measure Success....... 15
What a Bio-based Economy Means for Canadians....... 16
Conclusion: We Can Build Our Future....... 17
Biotechnology Milestones....... 18
References....... 19
Building Beyond Moose and Mountains....... 19
 
 
 
About the “Canadian Blueprint”
 
What do compostable plastic bags, cold water laundry detergent and life-saving vaccines all have in common? They are all biotechnology products that make our lives healthier, safer, cleaner and better.
 
Biotechnology is creating products and processes that improve our quality of life. Just as importantly, biotechnology is also creating high-quality jobs for Canadians in every part of the country; rewarding, knowledge economy jobs.

No matter where we live, we all have a stake in the bio-based economy.

The “Canadian Blueprint” is a strategy that will enable us to take full advantage of all the opportunities biotechnology has to offer, provided all stakeholders do what is required of them.

This document is a call to action. The Canadian Blueprint is vitally important because, the fact is, biotechnology is critical to Canada’s future prosperity and economic security.
 
...........(계속)
 
 
 
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.
 
 
 
 
관련기사
셀트리온 '램시마', 캐나다서 염증성 장질환약으로 판매 허가 2016-06-15
혈액제제 최대 시장 북미 “열려라 참깨” 녹십자 ‘IVIG-SN 10%’ 캐나다서 임상3상 승인 2016-03-10
캐나다, 의료기기 시장 진출방안 2016-03-09
알테오젠, 허셉틴 바이오시밀러 캐나다 임상1상 승인 2016-02-29
녹십자, 캐나다 혈액제제 공장 착공 2016-02-24
캐나다서 암초 걸린 ‘베네팔리’, 유럽도 ‘불안불안’ 2016-02-22
캐나다의 의약품 특허목록 등재 심사 관련 통계로 살펴본 식약처의 특허목록 등재 심사에 대한 소고 2016-02-16
국산 ‘엔브렐’ 바이오시밀러 해외 진출 ‘난항’삼성, 캐나다서 특허소송 중 2016-01-12
미국과 캐나다는 개발도상국의 연구중심에 2천1백만불을 투자 2015-10-27
녹십자, 캐나다 공장 착공…북미 의약품시장 공략 나서 2015-06-03